Opternative Revolutionizes Eye Exams with Launch of Online, Ophthalmologist-Issued Prescription Service for Glasses and Contacts

CHICAGO–(BUSINESS WIRE)–Opternative, the world’s first online eye exam service, is now available to provide consumers with a convenient and affordable physician-issued prescription for glasses or contacts. By using a computer and smartphone, consumers can take a 25-minute or less eye exam from the comfort of home and receive a prescription within 24 hours to use at any online or neighborhood optical retailer. Opternative exams cost $40 for a prescription for glasses or contacts and $60 for bo


CMC Biologics, River Vision sign manufacturing agreement for Teprotumumab to treat Grave’s Orbitopathy

CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave’s Orbitopathy and other indications.

Hoya Reports First Quarter Financial Results

TOKYO–(BUSINESS WIRE)–HOYA Corporation (TOKYO:7741) today announced financial results for the first quarter ended June 30, 2015. During the quarter, revenues increased by 11.6% to 126,238 million yen compared with the same period last year. Pre-tax p…